HealthQuill Articles by: HealthQuill
A zamorin, an ailing British judge, and a group of physicians played crucial roles in establishing the world’s first Ayurvedic hospital in 1902.
Drugs Health Opinion

How a zamorin, a British judge, helped build world’s first ayurvedic hospital

HQ Team April 27, 2024: A zamorin, an ailing British judge, and a group of physicians played crucial roles in establishing the world’s

Read More
Climate Health Research

UN for new equity-based, resilient model for Asia-Pacific megacities 

HQ Team April 27, 2025: As the climate crisis pushes many of Asia’s sprawling megacities to their limits, a UN body has called

Read More
Italfarmaco SpA., a privately held Italian pharmaceutical and chemical company, received a recommendation for the conditional marketing in the European Union of an oral drug for Duchenne muscular dystrophy in patients six years or older, who can walk.
Drugs Medical Pharma

Italfarmaco gets conditional marketing nod in EU for DMD drug

HQ Team April 27, 2025: Italfarmaco SpA., a privately held Italian pharmaceutical and chemical company, received a recommendation for the conditional marketing in

Read More
The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating thyroid eye disease, according to a statement.
Drugs Medical Pharma

Amgen’s thyroid eye disease medicine gets EU market authorisation

HQ Team April 27, 2025: The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating

Read More
Johnson & Johnson’s investigational treatment to help people with a specific type of early-stage bladder cancer has shown 80% of the patients to be free of cancer for up to nine months, and 94% were able to avoid surgical removal of the organ after a year of follow-up.
Drugs Health Pharma

J&J’s trial drug for a type of bladder cancer helps avoid organ removal 

HQ Team April 27, 2025: Johnson & Johnson’s investigational treatment to help people with a specific type of early-stage bladder cancer has shown

Read More
Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health Organization.
Drugs Health Pharma

Uganda declares Ebola disease outbreak to be over, WHO says

HQ Team April 26, 2025: Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health

Read More
Amgen Inc. will expand its Ohio biomanufacturing facility for $900 million, after a recent move to invest $1 billion to build a second manufacturing plant in Holly Springs, North Carolina, US.
Drugs Medical Pharma

Amgen to invest $900 million in Ohio biomanufacturing facility

HQ Team April 26, 2025: Amgen Inc. will expand its Ohio biomanufacturing facility for $900 million, after a recent move to invest $1 billion to

Read More
More than 84% of 345 information technology workers surveyed in an Indian city suffer from non-alcoholic fatty liver disease due to sedentary lifestyles, posing a significant health challenge, according to a study.
Drugs Health Research

In Hyderabad, India, 84% of IT workers have non-alcoholic fatty liver

HQ Team April 24, 2025: More than 84% of 345 information technology workers surveyed in an Indian city suffer from non-alcoholic fatty liver

Read More
UNOPS stands for the United Nations Office for Project Services. It is a UN agency that implements humanitarian and development projects for the UN system, international financial institutions, and other partners. UNOPS provides infrastructure, procurement, and project management services to support peace and security, humanitarian, and development initiatives globally.
Drugs Health Pharma

UN body cuts price of medicine to combat multidrug-resistant TB

HQ Team April 23, 2025: A UN agency, the Stop TB Partnership’s Global Drug Facility (GDF), cut the price of pretomanid, a key

Read More
Bristol Myers Squibb’s investigational oral drug for treating schizophrenia in adults failed in its main goal to treat symptoms in patients who are already on regular medication.
Drugs Health Pharma

Bristol Myers’ oral medication for schizophrenia fails to meet main goal

HQ Team April 23: Bristol Myers Squibb’s investigational oral drug for treating schizophrenia in adults failed in its main goal to treat symptoms

Read More